Richard Bertz

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 10

Top Topics

Aortic Dissection

Placebo Controlled

Top Venues

Clinical and translational science

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)